Cargando…

Unexpected phenotypic and molecular changes of combined glucocerebrosidase and acid sphingomyelinase deficiency

Heterozygous variants in GBA1, encoding glucocerebrosidase (GCase), are the most common genetic risk factor for Parkinson's disease (PD). Moreover, sporadic PD patients also have a substantial reduction of GCase activity. Genetic variants of SMPD1 are also overrepresented in PD cohorts, whereas...

Descripción completa

Detalles Bibliográficos
Autores principales:	Keatinge, Marcus, Gegg, Matthew E., Watson, Lisa, Mortiboys, Heather, Li, Nan, Dunning, Mark, Ailani, Deepak, Bui, Hai, van Rens, Astrid, Lefeber, Dirk J., Schapira, Anthony H. V., MacDonald, Ryan B., Bandmann, Oliver
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Company of Biologists Ltd 2023
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10184672/ https://www.ncbi.nlm.nih.gov/pubmed/36951087 http://dx.doi.org/10.1242/dmm.049954

Ejemplares similares

Mitochondrial dysfunction associated with glucocerebrosidase deficiency
por: Gegg, Matthew E., et al.
Publicado: (2016)

Glucocerebrosidase 1 deficient Danio rerio mirror key pathological aspects of human Gaucher disease and provide evidence of early microglial activation preceding alpha-synuclein-independent neuronal cell death
por: Keatinge, Marcus, et al.
Publicado: (2015)

Glucocerebrosidase deficiency promotes release of α-synuclein fibrils from cultured neurons
por: Gegg, Matthew E, et al.
Publicado: (2020)

Glucocerebrosidase Deficiency in Substantia Nigra of Parkinson Disease Brains
por: Gegg, Matthew E, et al.
Publicado: (2012)

Autophagic lysosome reformation dysfunction in glucocerebrosidase deficient cells: relevance to Parkinson disease
por: Magalhaes, Joana, et al.
Publicado: (2016)

Glucocerebrosidase activity, cathepsin D and monomeric α-synuclein interactions in a stem cell derived neuronal model of a PD associated GBA1 mutation
por: Yang, Shi-yu, et al.
Publicado: (2020)

Glucocerebrosidase mutations and Parkinson disease
por: Vieira, Sophia R. L., et al.
Publicado: (2022)

Inhibition of the mitochondrial calcium uniporter rescues dopaminergic neurons in pink1 (−/−) zebrafish
por: Soman, Smijin, et al.
Publicado: (2016)

Ambroxol improves lysosomal biochemistry in glucocerebrosidase mutation-linked Parkinson disease cells
por: McNeill, Alisdair, et al.
Publicado: (2014)

Neurological effects of glucocerebrosidase gene mutations
por: Mullin, S., et al.
Publicado: (2018)

The relationship between glucocerebrosidase mutations and Parkinson disease
por: Migdalska‐Richards, Anna, et al.
Publicado: (2016)

Novel pathogenic mutations in the glucocerebrosidase locus
por: Duran, Raquel, et al.
Publicado: (2012)

Biochemical consequences of glucocerebrosidase 1 mutations in Parkinson’s disease
por: Yoon, Jeong Hyun, et al.
Publicado: (2023)

Ambroxol effects in glucocerebrosidase and α‐synuclein transgenic mice
por: Migdalska‐Richards, Anna, et al.
Publicado: (2016)

Clinical Trial Highlights: Modulators of Mitochondrial Function
por: Capriglia, Francesco, et al.
Publicado: (2023)

Oral ambroxol increases brain glucocerebrosidase activity in a nonhuman primate
por: Migdalska‐Richards, Anna, et al.
Publicado: (2017)

Restriction of mitochondrial calcium overload by mcu inactivation renders a neuroprotective effect in zebrafish models of Parkinson's disease
por: Soman, Smijin K., et al.
Publicado: (2019)

Glucocerebrosidase inhibition causes mitochondrial dysfunction and free radical damage
por: Cleeter, Michael W.J., et al.
Publicado: (2013)

Rescue of mitochondrial function in parkin-mutant fibroblasts using drug loaded PMPC-PDPA polymersomes and tubular polymersomes
por: Yealland, G., et al.
Publicado: (2016)

A clinical and family history study of Parkinson's disease in heterozygous glucocerebrosidase mutation carriers
por: McNeill, Alisdair, et al.
Publicado: (2012)

Parkinsonisms and Glucocerebrosidase Deficiency: A Comprehensive Review for Molecular and Cellular Mechanism of Glucocerebrosidase Deficiency
por: Gatto, Emilia M., et al.
Publicado: (2019)

Rapamycin activation of 4E-BP prevents parkinsonian dopaminergic neuron loss
por: Tain, Luke S, et al.
Publicado: (2009)

Brain Microglial Activation Increased in Glucocerebrosidase (GBA) Mutation Carriers without Parkinson's disease
por: Mullin, Stephen, et al.
Publicado: (2020)

Parkinsonism Associated with Glucocerebrosidase Mutation
por: Sunwoo, Mun-Kyung, et al.
Publicado: (2011)

Glucocerebrosidase mutations in primary parkinsonism
por: Asselta, Rosanna, et al.
Publicado: (2014)

Glucocerebrosidase: Functions in and Beyond the Lysosome
por: Boer, Daphne E.C., et al.
Publicado: (2020)

Progranulin deficiency leads to reduced glucocerebrosidase activity
por: Zhou, Xiaolai, et al.
Publicado: (2019)

Glucocerebrosidase is imported into mitochondria and preserves complex I integrity and energy metabolism
por: Baden, Pascale, et al.
Publicado: (2023)

Sex-Specific Microglial Responses to Glucocerebrosidase Inhibition: Relevance to GBA1-Linked Parkinson’s Disease
por: Brunialti, Electra, et al.
Publicado: (2023)

Glucocerebrosidase and its relevance to Parkinson disease
por: Do, Jenny, et al.
Publicado: (2019)

Stabilization of Glucocerebrosidase by Active Site Occupancy
por: Ben Bdira, Fredj, et al.
Publicado: (2017)

Mitochondrial Contribution to Parkinson's Disease Pathogenesis
por: Schapira, Anthony H. V., et al.
Publicado: (2011)

Sphingomyelinases and Liver Diseases
por: Insausti-Urkia, Naroa, et al.
Publicado: (2020)

Glucocerebrosidase Involvement in Parkinson Disease and Other Synucleinopathies
por: Almeida, Maria do Rosário
Publicado: (2012)

Ambroxol as a pharmacological chaperone for mutant glucocerebrosidase
por: Bendikov-Bar, Inna, et al.
Publicado: (2013)

Progressive decline of glucocerebrosidase in aging and Parkinson's disease
por: Rocha, Emily M, et al.
Publicado: (2015)

Longitudinal Measurements of Glucocerebrosidase activity in Parkinson’s patients
por: Alcalay, Roy N., et al.
Publicado: (2020)

Evaluation of Strategies for Measuring Lysosomal Glucocerebrosidase Activity
por: Ysselstein, Daniel, et al.
Publicado: (2021)

Consequences of excessive glucosylsphingosine in glucocerebrosidase-deficient zebrafish.
por: Lelieveld, Lindsey T., et al.
Publicado: (2022)

Xylose‐Configured Cyclophellitols as Selective Inhibitors for Glucocerebrosidase
por: Su, Qin, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_2n45g552tdujv3ih91vfoekmb5